ViaDerma, Inc. Announces Preston Richards to Join Advisory Board
January 22, 2015 09:01 ET
|
ViaDerma Licensing
LOS ANGELES, Jan. 22, 2015 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC:VDRM), a developer of advanced topical pharmaceuticals, is pleased to announce the addition of Preston Richards to their Advisory...
ViaDerma, Inc. Launches New Website
January 13, 2015 09:01 ET
|
ViaDerma Licensing
LOS ANGELES, Jan. 13, 2015 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC:VDRM), a specialty pharmaceutical company devoted to bringing new products to the market, is excited to officially announce its new...
TetraStem(TM) Antibiotic Continues to Demonstrate Treatment Success Leading Management to Explore Partnerships With Big Pharmaceutical Companies
December 09, 2014 09:44 ET
|
ViaDerma Licensing
LOS ANGELES, Dec. 9, 2014 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC:VDRM), a specialty pharmaceutical company devoted to bringing new products to market, recently announced TetraStemTM, a topical liquid...
ViaDerma, Inc. Lead Product TetraStem Shows Promise in Treating Acne
November 21, 2014 10:16 ET
|
ViaDerma Licensing
LOS ANGELES, Nov. 21, 2014 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTCQB:VDRM), a specialty pharmaceutical company devoted to bringing new products to market, has recently released a revolutionary new...
ViaDerma, Inc. Appoints Dr. Andrew Berman as Medical Director of Advisory Board
November 13, 2014 11:26 ET
|
ViaDerma Licensing
LOS ANGELES, Nov. 13, 2014 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTCQB:VDRM), a specialty pharmaceutical company devoted to bringing new products to market, is pleased to announce the appointment of Dr....
TetraStem, Lead Product of ViaDerma, Inc., Hopes to Slow Rates of Diabetic Amputations
November 07, 2014 08:54 ET
|
ViaDerma Licensing
LOS ANGELES, Nov. 7, 2014 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTCQB:VDRM), a specialty pharmaceutical company devoted to bringing new products to market, has recently released a revolutionary new...